Treatment of spastic cerebral-palsied children with sodium dantrolene.
D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D012640:Seizures / Q000139:chemically induced; D013035:Spasm / Q000188:drug therapy*
D006827:Hydantoins; D003620:Dantrolene